Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2

P. J. White, G. P. Garnett*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

Background: Genital infection with herpes simplex virus (HSV) is common and can cause severe morbidity, over many years in some cases. Aciclovir provides suppressive therapy but there is debate over the effects of its use on the spread of infection. Objectives: To explore the influence of the natural history of genital HSV and the impact of antiviral therapy. Methods: A simple mathematical model of HSV-2 transmission dynamics was developed, and parameter values estimated from published data. Results: The relative durations of the risk of transmitting HSV-2 and the duration of therapy generate a non-linear relation between the duration of antiviral therapy and the reduction in prevalence of infection. If there is a wide distribution of risk of HSV-2 transmission over the course of an infection then practicable aciclovir use is unlikely to have any great impact on disease transmission dynamics. Conclusions: There are still many uncertainties in the transmission dynamics of HSV-2. In particular, infectiousness over the course of an infection requires more detailed exploration. To have a significant impact on the prevalence of HSV-2 aciclovir use would have to be widespread and for a long duration.

Original languageEnglish
Pages (from-to)49-54
Number of pages6
JournalSexually Transmitted Infections
Volume75
Issue number1
DOIs
Publication statusPublished - 1999
Externally publishedYes

Keywords

  • Antiviral therapy
  • Herpes simplex virus type 2
  • Mathematical model

Fingerprint

Dive into the research topics of 'Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2'. Together they form a unique fingerprint.

Cite this